Drug Database
Back to search

United States· US:43068-112_2609a5b3-d7ec-48a9-a32b-54a9b207f9aa

FANAPT

A iloperidone product containing iloperidone, registered in United States by Vanda Pharmaceuticals Inc..

ATC N05AX14US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedFANAPTATCN05AX14REGISTER NO.US:43068-112_2609a5b3…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about iloperidoneAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
ILOPERIDONE
Manufacturer
Vanda Pharmaceuticals Inc.
Country
United States (US)
ATC code
N05AX14
ATC class
Iloperidone
Defined daily dose
18 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    4306811202
    60 TABLET in 1 BOTTLE (43068-112-02)
  • ndc11
    43068-112-02

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

320 interactions on record for iloperidone.

Graded by severity as the source publishes them — 141 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check iloperidone against other medicinesHow interaction checks work

Iloperidone · interactions on record

320 records

  • 141 severe
  • 177 moderate
  • 2 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • MetoclopramideA03FA01severe
  • CisaprideA03FA02severe
  • OndansetronA04AA01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under N05AX14

Iloperidone, as other registers publish it.

All iloperidone products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d2513f08-df5a-4cab-a539-bd70b520121a
GET /v1/drugs/d2513f08-df5a-4cab-a539-bd70b520121a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "12",
  "substance": "ILOPERIDONE",
  "productndc": "43068-112",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "NDA022192",
  "marketing_category": "NDA"
}
API referenceMCP serverPlans

See everything about iloperidone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console